Femasys Inc. (Nasdaq: FEMY) is a biomedical innovator focused on transforming women's reproductive healthcare. The company develops and commercializes a suite of product candidates, including minimally invasive, in-office technologies for fertility treatment and permanent birth control, as well as diagnostic tools. Their solutions aim to expand access to care, improve outcomes, and reduce costs for women worldwide.